denotes an abstract that is clinically relevant.
denotes that this is a ticketed session.
Program: General Sessions
Tuesday, December 8, 2020: 1:30 PM-3:00 PM
Co-chairs:
Alisa S. Wolberg, PhD, University of North Carolina at Chapel Hill
and
Leslie Kean, MD, PhD, Boston Children's Hospital
Disclosures:
Wolberg: Bristol-Myers_Squibb: Research Funding; GlaxoSmithKline: Other: Spouse employment; Takeda: Research Funding. Kean: magenta: Research Funding; Bristol Meyers Squibb: Research Funding; kymab: Consultancy; hifibio: Consultancy; regeneron: Research Funding; novartis: Consultancy; gilead: Research Funding; bluebird bio: Research Funding; fortyseven: Consultancy.
Before heading home, make time to attend this 90-minute session for a review of the key themes from this year's meeting. Led by the 2020 Scientific Program co-chairs, Best of ASH is your opportunity to hear about the biggest breakthroughs from the meeting's scientific presentations.
See more of: General Sessions